Status:
COMPLETED
An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269)
Lead Sponsor:
Organon and Co
Conditions:
Rhinitis, Allergic, Seasonal
Asthma, Bronchial
Eligibility:
All Genders
15-85 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine the effect of an approved medication on the symptoms of seasonal allergic rhinitis (a seasonal variety of inflammation of the mucous membrane of the nose) in ...
Detailed Description
The duration of treatment is 2 weeks.
Eligibility Criteria
Inclusion
- Non-smoker
- A 2-year documented history of seasonal allergic rhinitis
- A 1-year documented history of chronic asthma
- Positive allergy testing
Exclusion
- Medical history of a lung disorder (other than asthma) or a recent upper respiratory tract infection.
Key Trial Info
Start Date :
March 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2003
Estimated Enrollment :
831 Patients enrolled
Trial Details
Trial ID
NCT00092885
Start Date
March 1 2003
End Date
October 1 2003
Last Update
August 15 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.